首页> 外文期刊>Basic & clinical pharmacology & toxicology. >Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
【24h】

Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.

机译:可乐定对自发性高血压大鼠肾上腺髓质和大脑酪氨酸羟化酶活性的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

In the present study, we evaluated the effect of the alpha(2)-adrenoceptor agonist clonidine on tyrosine hydroxylase activity in adrenal medulla and brain of spontaneously hypertensive rats and Wistar Kyoto rats. Six-week-old animals were treated with clonidine (100 microg/kg body weight, daily, i.p.) for 4 weeks. Treatment with clonidine significantly reduced mean arterial blood pressure in spontaneously hypertensive rats to values similar to normotensive Wistar Kyoto rats. In the adrenal medulla of spontaneously hypertensive rats, clonidine treatment produced a significant increase in tyrosine hydroxylase activity with higher V(max) values and no changes in K(M) values. This effect was accompanied by a significant increase in tyrosine hydroxylase protein expression and of noradrenaline and adrenaline levels. In the brain of spontaneously hypertensive rats, treatment with clonidine produced a significant decrease in tyrosine hydroxylase activity with lower V(max) values and no changes in K(M) values accompanied by a significant decrease in tyrosine hydroxylase protein expression and of dopamine and noradrenaline levels. In Wistar Kyoto rats, clonidine treatment had no effect on tyrosine hydroxylase activity and protein expression or catecholamine levels in adrenal medulla or brain. Clonidine treatment significantly reduced noradrenaline and adrenaline plasma levels in spontaneously hypertensive rats and Wistar Kyoto rats. In conclusion, treatment with the alpha(2)-adrenoceptor agonist clonidine prevented the increase in mean arterial blood pressure in young spontaneously hypertensive rats. This effect was accompanied by opposite effects on tyrosine hydroxylase activity in spontaneously hypertensive rat adrenal medulla and brain: an increase in adrenal medulla and a decrease in brain, bringing sympathetic function to a similar profile found in normotensive Wistar Kyoto rats.
机译:在本研究中,我们评估了α(2)-肾上腺素受体激动剂可乐定对自发性高血压大鼠和Wistar Kyoto大鼠肾上腺髓质和大脑中酪氨酸羟化酶活性的影响。六周大的动物用可乐定(100微克/千克体重,每天,腹腔注射)治疗4周。可乐定治疗可将自发性高血压大鼠的平均动脉血压显着降低至与正常血压的Wistar Kyoto大鼠相似的值。在自发性高血压大鼠的肾上腺髓质中,可乐定治疗可显着增加酪氨酸羟化酶的活性,并具有较高的V(max)值,而K(M)值无变化。这种作用伴随着酪氨酸羟化酶蛋白表达以及去甲肾上腺素和肾上腺素水平的显着增加。在自发性高血压大鼠的大脑中,用可乐定治疗可显着降低酪氨酸羟化酶活性,降低V(max)值,而K(M)值无变化,同时酪氨酸羟化酶蛋白表达以及多巴胺和去甲肾上腺素显着降低水平。在Wistar Kyoto大鼠中,可乐定治疗对肾上腺髓质或大脑中的酪氨酸羟化酶活性和蛋白质表达或儿茶酚胺水平没有影响。可乐定治疗可显着降低自发性高血压大鼠和Wistar Kyoto大鼠的去甲肾上腺素和肾上腺素血浆水平。总之,用α(2)-肾上腺素受体激动剂可乐定治疗可防止年轻的自发性高血压大鼠平均动脉血压的升高。这种作用伴随着对自发性高血压大鼠肾上腺髓质和大脑中酪氨酸羟化酶活性的相反影响:肾上腺髓质的增加和大脑的减少,使交感神经功能与正常血压的Wistar Kyoto大鼠中发现的相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号